A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Clinical trial NCT00373113 · TERMINATED

Trial details

NCT number: NCT00373113
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2006-11-01
Primary completion: 2009-10-01
Enrollment: 482

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.